Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Alessia
Contact Alessia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Clinical Management of Long-Term Survivors after Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma
Open AccessEditorial by Alessia Bari 1,*, Chiara Gerardi 2, Eleonora Allocati 2, Agata Puzzovivo 3, Vitaliana De Sanctis 4, Alessandra Tucci 5, Monica Balzarotti 6, Silvia Franceschetti 7, Francesco Merli 8, Attilio Guarini 9, Guido Gini 10 and Carla Minoia 9 1 Dipartimento di Scienze Mediche e Chirurgiche, Materno-Infantili e dell’Adulto, Università di Modena e Reggio Emilia, 41124 Modena, Italy 2 Istituto di Ricerche Farmacologiche “Mario Negri” IRCCS, 20156 Milan, Italy 3 Cardioncology...
A concise review of lenalidomide therapy for follicular lymphoma
Introduction: Lenalidomide, first introduced for the treatment of multiple myeloma in 2008, has been used in the treatment of various subtypes of non-Hodgkin lymphoma (NHL). Considering its mechanism of action, it has been associated with rituximab, showing strong activity in follicular lymphomas (FL). As the chemo-free treatments are a topic of great relevance we decided to prepare a concise review mainly directed to clinicians involved in the management of NHL patients.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Alessia
Contact Alessia, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack